Ananth has more than 20 years’ experience in pharmaceutical consulting across a variety of disciplines, including quantitative systems pharmacology modeling, health economic modeling, systemic literature reviews, indirect treatment comparisons, and complex statistical analyses of clinical and real-world databases required to support regulatory, payer and HTA submissions worldwide.
Ananth Kadambi, PhD
VP, Real World Evidence & Modeling Solutions
Related resources
Beyond approval: Using model-informed strategies to maximize the value of ADCs
Blog
Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access
On-Demand Webinar
Why the most important Phase 3 decisions should be made before Phase 3
Blog
Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access
Webinar
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy
On-Demand Webinar